CHOAY Tablet

Enzymatic anti-oedena and anti-inflammatory:

Treatment of post-traumatic or postoperation oedma (i.e., soft tissue injuries, acute traumatic injuries, sprains, contusions, hematomas, ecchymoses, infections, edma of the eyelids, muscle cramps, and sports injuries).

Oral route:

2 tablets. 3-4 times/day.

Tablets should also betaken with at least 8 oz equivalent to 240 ml of water to help activate the enzyme.

Sublingual:

4-6tablets/day in divided doses. Tablet should be slowly dissolved under the tongue.

Allergic to any components of the product.

Chymotrypsine is dontraindicated in patients with decreased alpha 1 antitrypsine. Generally, patients with COPD, especially emphysema and patients presenting with nephrotic syndrome are also likely candidates for decreased alpha 1 antitrypsine.

- There do not appear to be any long-term side effects from chymotrypsin therapy if precautions for its use are folowed in precaution in use.

- Studies have shown that at recommended doses, enzymes cannot be detected in blood analysis after 24-48 hours. Temporary side effects that may occur (but that should disappear when therapy is discontinued or dosage is reduced) include changes in the color, consistency, and odor of the stool. Some individuals may experience gastrointestinal disturbances, such as flatulence, a feeling of fullness, diarrhea, constipation, or nausea.

- With high doses, minor allergic reations such as reddening of the skin may occur.

- Chymotrypsine is most often used in combination with other enzymes to enhance its treatment potential. In addition, a well-balanced diet or the use of vitamin and mineral supplements are recommended to stimulate chymotrypsine activity.

- Sine types of seeds, including jojoba and wild soja seeds, have been found to contain proteins that inhibit the activity of chymotrypsine. These proteins can be inactivated by boiling the seeds.

- Chymotrypsine should not be used together with acerylcysteine, a drug used to thin mucus in the lungs, and it should also not be used together with anticoagulant (blood thinning) drugs, as it increases their effects,

should not be used for pregnant and breast-feeding women.

- Chymotrypsine is generally well tolerated and not associated with any significant side effects.

- People who should not use enzyme therapy include those with hereditary clotting disorders such as hemophilia, those suffering from coagulation disturbances, those who are just about to or have undergone surgery, those on anticoagulant therapy, anyone suffering from protein allergies, and pregnant women or those breast-feeding, patient has stomach ulcers.